Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya M Zeineddine

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 25, 2020
Treatment of multiple sclerosis in special populations: The case of refugeesMaya M Zeineddine, Bassem I Yamout
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2017
Letter to the editorBassem I Yamout, Maya M Zeineddine
Journal of Pharmacy Practice|June 28, 2013
Effect of pharmacy practice program on pharmacy student learning, satisfaction, and efficiency: assessment of introductory pharmacy practice courseAbeer A Zeitoun, Hiyam L El Zein, Maya M Zeineddine
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2017
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorderBassem I Yamout, Shawkat Beaini, Maya M Zeineddine, et al.
Journal of Neuroimmunology|December 1, 2015
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle EastBassem I Yamout, Maya M Zeineddine, Hani Tamim, et al.
Journal of Neuroimmunology|July 23, 2015
Safety and efficacy of reduced fingolimod dosage treatmentBassem I Yamout, Maya M Zeineddine, Raja A Sawaya, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Three cases of herpes zoster radiculitis in MS patients treated with natalizumabBassem I Yamout, Nuhad Abou Zeid, Ali J Taha, et al.
Journal of Immunology Research|December 13, 2018
Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational StudyBassem I Yamout, Nabil K El-Ayoubi, Johny Nicolas, et al.
Multiple Sclerosis and Related Disorders|July 9, 2018
Efficacy and safety of natalizumab extended interval dosingBassem I Yamout, Mohamad Ali Sahraian, Nabil El Ayoubi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 25, 2020
Treatment of multiple sclerosis in special populations: The case of refugeesMaya M Zeineddine, Bassem I Yamout
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2017
Letter to the editorBassem I Yamout, Maya M Zeineddine
Journal of Pharmacy Practice|June 28, 2013
Effect of pharmacy practice program on pharmacy student learning, satisfaction, and efficiency: assessment of introductory pharmacy practice courseAbeer A Zeitoun, Hiyam L El Zein, Maya M Zeineddine
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2017
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorderBassem I Yamout, Shawkat Beaini, Maya M Zeineddine, et al.
Journal of Neuroimmunology|December 1, 2015
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle EastBassem I Yamout, Maya M Zeineddine, Hani Tamim, et al.
Journal of Neuroimmunology|July 23, 2015
Safety and efficacy of reduced fingolimod dosage treatmentBassem I Yamout, Maya M Zeineddine, Raja A Sawaya, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Three cases of herpes zoster radiculitis in MS patients treated with natalizumabBassem I Yamout, Nuhad Abou Zeid, Ali J Taha, et al.
Journal of Immunology Research|December 13, 2018
Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational StudyBassem I Yamout, Nabil K El-Ayoubi, Johny Nicolas, et al.
Multiple Sclerosis and Related Disorders|July 9, 2018
Efficacy and safety of natalizumab extended interval dosingBassem I Yamout, Mohamad Ali Sahraian, Nabil El Ayoubi, et al.
Pageof 1